Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125842982 | 12584298 | 2 | F | 20140607 | 20160722 | 20160722 | 20160801 | EXP | TW-PFIZER INC-3130624 | PFIZER | 57.00 | YR | F | Y | 0.00000 | 20160801 | CN | US | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125842982 | 12584298 | 1 | PS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 278.64 MG, CYCLIC | Y | 77915 | 278.64 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 2 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 247.68 MG, CYCLIC | Y | 77915 | 247.68 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 3 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 247.68 MG, CYCLIC | Y | 77915 | 247.68 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 4 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 247.68 MG, CYCLIC | Y | 77915 | 247.68 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 5 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 247.68 MG, CYCLIC | Y | 77915 | 247.68 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 6 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 247.68 MG, CYCLIC | Y | 77915 | 247.68 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 7 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 274.67 MG, CYCLIC | Y | 77915 | 274.67 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 8 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | 247.68 MG, CYCLIC | Y | 77915 | 247.68 | MG | SOLUTION FOR INJECTION | |||||||
125842982 | 12584298 | 9 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | 688 MG, CYCLIC | Y | 8107 | 688 | MG | ||||||||
125842982 | 12584298 | 10 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | 688 MG, CYCLIC | Y | 8107 | 688 | MG | ||||||||
125842982 | 12584298 | 11 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | 688 MG, CYCLIC | Y | 8107 | 688 | MG | ||||||||
125842982 | 12584298 | 12 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | 688 MG, CYCLIC | Y | 8107 | 688 | MG | ||||||||
125842982 | 12584298 | 13 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | 688 MG, CYCLIC | Y | 8107 | 688 | MG | ||||||||
125842982 | 12584298 | 14 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | 688 MG, CYCLIC | Y | 8107 | 688 | MG | ||||||||
125842982 | 12584298 | 15 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | 688 MG, CYCLIC | Y | 8107 | 688 | MG | ||||||||
125842982 | 12584298 | 16 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 4403.2 MG, CYCLIC | Y | 0 | 4403.2 | MG | ||||||||
125842982 | 12584298 | 17 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 3990.4 MG, CYCLIC | Y | 0 | 3990.4 | MG | ||||||||
125842982 | 12584298 | 18 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 3990.4 MG, CYCLIC | Y | 0 | 3990.4 | MG | ||||||||
125842982 | 12584298 | 19 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 3990.4 MG, CYCLIC | Y | 0 | 3990.4 | MG | ||||||||
125842982 | 12584298 | 20 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 3990.4 MG, CYCLIC | Y | 0 | 3990.4 | MG | ||||||||
125842982 | 12584298 | 21 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 3990.4 MG, CYCLIC | Y | 0 | 3990.4 | MG | ||||||||
125842982 | 12584298 | 22 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 3990.4 MG, UNK | Y | 0 | 3990.4 | MG | ||||||||
125842982 | 12584298 | 23 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | UNK | Y | 0 | ||||||||||
125842982 | 12584298 | 24 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, 2 WEEKS | Y | 0 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
125842982 | 12584298 | 25 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, CYCLIC | Y | 0 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
125842982 | 12584298 | 26 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, 2 WEEKS | Y | 0 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
125842982 | 12584298 | 27 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, 2 WEEKS | Y | 0 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
125842982 | 12584298 | 28 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, 2 WEEKS | Y | 0 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
125842982 | 12584298 | 29 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, 2 WEEKS | Y | 0 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
125842982 | 12584298 | 30 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, 2 WEEKS | Y | 0 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
125842982 | 12584298 | 31 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | 5 MG, 3 WEEKS | Y | 0 | 5 | MG | SOLUTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125842982 | 12584298 | 1 | Colorectal cancer metastatic |
125842982 | 12584298 | 9 | Colorectal cancer metastatic |
125842982 | 12584298 | 16 | Colorectal cancer metastatic |
125842982 | 12584298 | 24 | Colorectal cancer metastatic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125842982 | 12584298 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125842982 | 12584298 | Febrile neutropenia | |
125842982 | 12584298 | Malaise | |
125842982 | 12584298 | Mucosal inflammation | |
125842982 | 12584298 | Neutrophil count decreased | |
125842982 | 12584298 | Pruritus | |
125842982 | 12584298 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125842982 | 12584298 | 1 | 20140524 | 20140607 | 0 | |
125842982 | 12584298 | 2 | 20140621 | 0 | ||
125842982 | 12584298 | 3 | 20140705 | 20140705 | 0 | |
125842982 | 12584298 | 4 | 20140719 | 20140719 | 0 | |
125842982 | 12584298 | 5 | 20140802 | 20140802 | 0 | |
125842982 | 12584298 | 6 | 20140816 | 20140816 | 0 | |
125842982 | 12584298 | 7 | 20140830 | 20140913 | 0 | |
125842982 | 12584298 | 8 | 20140927 | 0 | ||
125842982 | 12584298 | 9 | 20140524 | 20140524 | 0 | |
125842982 | 12584298 | 10 | 20140621 | 20140621 | 0 | |
125842982 | 12584298 | 11 | 20140705 | 20140705 | 0 | |
125842982 | 12584298 | 12 | 20140719 | 20140719 | 0 | |
125842982 | 12584298 | 13 | 20140802 | 20140802 | 0 | |
125842982 | 12584298 | 14 | 20140816 | 20140816 | 0 | |
125842982 | 12584298 | 15 | 20140830 | 20140830 | 0 | |
125842982 | 12584298 | 16 | 20140524 | 20140526 | 0 | |
125842982 | 12584298 | 17 | 20140621 | 0 | ||
125842982 | 12584298 | 18 | 20140705 | 20140707 | 0 | |
125842982 | 12584298 | 19 | 20140719 | 20140721 | 0 | |
125842982 | 12584298 | 20 | 20140802 | 20140804 | 0 | |
125842982 | 12584298 | 21 | 20140816 | 20140818 | 0 | |
125842982 | 12584298 | 22 | 20140830 | 20140901 | 0 | |
125842982 | 12584298 | 24 | 20140524 | 20140607 | 0 | |
125842982 | 12584298 | 25 | 20140621 | 20140621 | 0 | |
125842982 | 12584298 | 26 | 20140705 | 20140705 | 0 | |
125842982 | 12584298 | 27 | 20140719 | 20140719 | 0 | |
125842982 | 12584298 | 28 | 20140802 | 20140802 | 0 | |
125842982 | 12584298 | 29 | 20140816 | 20140816 | 0 | |
125842982 | 12584298 | 30 | 20140830 | 20140913 | 0 | |
125842982 | 12584298 | 31 | 20140927 | 0 |